Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

3.

Interactions of CD14 with components of gram-positive bacteria.

Dziarski R, Ulmer AJ, Gupta D.

Chem Immunol. 2000;74:83-107. Review. No abstract available.

PMID:
10608083
4.

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades.

Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S.

Int Immunol. 2000 Jan;12(1):113-7.

5.

Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT.

J Biol Chem. 1999 Nov 19;274(47):33419-25.

6.

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S.

Immunity. 1999 Oct;11(4):443-51.

7.

The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A.

Nature. 1999 Oct 21;401(6755):811-5.

PMID:
10548109
8.

Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.

Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ.

J Immunol. 1999 Oct 1;163(7):3920-7.

9.

Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome activation and IkappaB proteolysis.

Fischer C, Page S, Weber M, Eisele T, Neumeier D, Brand K.

J Biol Chem. 1999 Aug 27;274(35):24625-32.

10.

Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.

Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, Weis JJ.

J Immunol. 1999 Sep 1;163(5):2382-6.

11.

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL.

Science. 1999 Jul 30;285(5428):732-6.

12.

Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.

Yang RB, Mark MR, Gurney AL, Godowski PJ.

J Immunol. 1999 Jul 15;163(2):639-43.

13.

Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D.

J Immunol. 1999 Jul 1;163(1):1-5.

14.

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.

Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ.

J Biol Chem. 1999 Jun 18;274(25):17406-9.

15.

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M.

J Exp Med. 1999 Jun 7;189(11):1777-82.

16.

Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1.

Gupta D, Wang Q, Vinson C, Dziarski R.

J Biol Chem. 1999 May 14;274(20):14012-20.

17.

Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M.

J Biol Chem. 1999 Mar 19;274(12):7611-4.

18.

Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Qureshi ST, Larivière L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D.

J Exp Med. 1999 Feb 15;189(4):615-25. Erratum in: J Exp Med 1999 May 3;189(9):following 1518.

19.

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B.

Science. 1998 Dec 11;282(5396):2085-8.

20.

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.

Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M.

J Exp Med. 1998 Dec 7;188(11):2091-7.

Items per page

Supplemental Content

Write to the Help Desk